Effects of Cholinesterase Inhibitors on Postoperative Outcomes of Older Adults With Dementia Undergoing Hip Fracture Surgery

被引:16
作者
Seitz, Dallas P. [1 ,2 ]
Gill, Sudeep S. [3 ,4 ]
Gruneir, Andrea [2 ,3 ]
Austin, Peter C. [3 ,6 ]
Anderson, Geoff [3 ,6 ]
Reimer, Cara L. [5 ]
Rochon, Paula A. [2 ,3 ]
机构
[1] Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada
[2] Womens Coll Res Inst, Toronto, ON, Canada
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
[4] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[5] Queens Univ, Dept Anesthesia, Kingston, ON, Canada
[6] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada
基金
加拿大健康研究院;
关键词
Anesthesia; cholinesterase inhibitor; dementia; hip fracture; observational study; PROPENSITY SCORE METHODS; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; DONEPEZIL; DELIRIUM; THERAPY; SUXAMETHONIUM; DEFICIENCY; HYPOTHESIS; PREVENTION;
D O I
10.1097/JGP.0b013e3181ff67a1
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Cholinesterase inhibitors (ChEIs) may interact with muscle relaxants given during general anesthesia (GA), increasing the risk of postoperative complications. We evaluated the effects of ChEIs on the postoperative outcomes of older adults who underwent hip fracture surgery. Design: Population-based cohort study using linked administrative databases. Participants: All individuals with dementia age 66 years or older, who underwent hip fracture surgery between April 1, 2003, and December 31, 2007, in Ontario, Canada. Exposures: Use of any ChEI (donepezil, rivastigmine, or galantamine) before surgery. Outcomes: The primary composite outcome included any of the following: 30-day postoperative mortality; intensive care unit admissions; or in-hospital resuscitation. Secondary outcomes included postoperative respiratory failure and pneumonia. Analysis: We stratified the study sample on the basis of residence (community or long-term care [LTC]) and type of anesthetic (general or regional) to create four residence/anesthesia groups. We used propensity scores to match users and nonusers of ChEIs within the residence/anesthesia strata. We then calculated the relative risks (RR) and 95% confidence intervals (CI) for outcomes associated with ChEIs in the matched groups. Results: A total of 624 pairs of individuals from the community and 725 pairs from LTC were created among individuals who received GA. High rates of postoperative mortality and complications were observed in both ChEI users and nonusers. The RR of the primary outcome associated with ChEI use for individuals receiving GA was 0.88 (95% CI: 0.68-1.16; chi(2) = 0.93; df = 1; p = 0.34) and 0.82 (95% CI: 0.63-1.04; chi(2) = 2.59; df = 1; p = 0.11) in the community and LTC groups, respectively. In addition, ChEIs were not associated with any significant increased risk of postoperative respiratory complications. Conclusions: ChEI use was not associated with an increased risk of postoperative complications among older adults with dementia who underwent hip fracture surgery. However, the poor postoperative outcomes overall reinforced the need to prevent fractures and improve outcomes in this population. (Am J Geriatr Psychiatry 2011; 19:803-813)
引用
收藏
页码:803 / 813
页数:11
相关论文
共 51 条
  • [21] Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors A Population-Based Cohort Study
    Gill, Sudeep S.
    Anderson, Geoffrey M.
    Fischer, Hadas D.
    Bell, Chaim M.
    Li, Ping
    Normand, Sharon-Lise T.
    Rochon, Paula A.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (09) : 867 - 873
  • [22] Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries
    Gruber-Baldini, Ann L.
    Stuart, Bruce
    Zuckerman, Ilene H.
    Simoni-Wastila, Linda
    Miller, Ram
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (10) : 1508 - 1516
  • [23] A population-based study of cholinesterase inhibitor use for dementia
    Herrmann, Nathan
    Gill, Sudeep S.
    Bell, Chaim M.
    Anderson, Geoffrey M.
    Bronskill, Susan E.
    Shulman, Kenneth I.
    Fischer, Hadas D.
    Sykora, Kathy
    Shi, Haijiang Steven
    Rochon, Paula A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (10) : 1517 - 1523
  • [24] Management of mild to moderate Alzheimer's disease and dementia
    Hogan, David B.
    Bailey, Peter
    Carswell, Anne
    Clarke, Barry
    Cohen, Carole
    Forbes, Dorothy
    Man-Son-Hing, Malcolm
    Lanctot, Krista
    Morgan, Debra
    Thorpe, Lilian
    [J]. ALZHEIMERS & DEMENTIA, 2007, 3 (04) : 355 - 384
  • [25] Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence
    Hshieh, Tammy T.
    Fong, Tamara G.
    Marcantonio, Edward R.
    Inouye, Sharon K.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2008, 63 (07): : 764 - 772
  • [26] The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat
    Ibebunjo, C
    Donati, F
    Fox, GS
    Eshelby, D
    Tchervenkov, JI
    [J]. ANESTHESIA AND ANALGESIA, 1997, 85 (02) : 431 - 436
  • [27] Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
    Jann, MW
    Shirley, KL
    Small, GW
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (10) : 719 - 739
  • [28] Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials
    Kavirajan, Harish
    Schneider, Lon S.
    [J]. LANCET NEUROLOGY, 2007, 6 (09) : 782 - 792
  • [29] Lanctôt KL, 2003, CAN MED ASSOC J, V169, P557
  • [30] Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67